Jingxiao Wang

发表

Role of the Notch signaling in cholangiocarcinoma

D. Calvisi, Xin Chen, A. Cigliano, 2017, Expert opinion on therapeutic targets.

A human multi-lineage hepatic organoid model for liver fibrosis

Manhong Wu, G. Peltz, A. Enejder, 2020, Nature Communications.

Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis

D. Calvisi, G. Giannelli, Xin Chen, 2020, Cell Death & Differentiation.

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma

D. Calvisi, Xin Chen, Meng Xu, 2020, Gut.

The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease

D. Calvisi, G. Giannelli, Xin Chen, 2022, Journal of Experimental & Clinical Cancer Research.

Pathogenesis from Inflammation to Cancer in NASH-Derived HCC

Jielu Yan, Simiao Yu, Jingxiao Wang, 2022, Journal of hepatocellular carcinoma.

mTORC2 signaling is necessary for timely liver regeneration after partial hepatectomy.

D. Calvisi, Xin Chen, Rong Li, 2020, The American journal of pathology.

Responses of phytoplankton communities driven by differences of source water intrusions in the El Niño and La Niña events in the Taiwan Strait during the early spring

Bangqin Huang, Xin Liu, E. Laws, 2022, Frontiers in Marine Science.

Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma

D. Calvisi, Xin Chen, Hongbo Hu, 2018, Clinical Cancer Research.

CDK9 is dispensable for YAP‐driven hepatoblastoma development

D. Calvisi, Xin Chen, S. Zhong, 2020, Pediatric blood & cancer.

Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition

D. Calvisi, G. Giannelli, Xin Chen, 2022, Journal of Experimental & Clinical Cancer Research.

Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans.

D. Calvisi, Xin Chen, W. Cong, 2018, The American journal of pathology.

Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice

D. Calvisi, Xin Chen, J. Gordan, 2018, Oncogene.

Focal Adhesion Kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation.

R. Schwabe, D. Calvisi, Xin Chen, 2021, Journal of hepatology.

Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.

Darjus F. Tschaharganeh, D. Calvisi, Xin Chen, 2017, Cancer research.

Axis inhibition protein 1 (Axin1) Deletion–Induced Hepatocarcinogenesis Requires Intact β‐Catenin but Not Notch Cascade in Mice

D. Calvisi, Xin Chen, J. Tao, 2019, Hepatology.

Loss of Fbxw7 synergizes with activated AKT signaling to promote c-Myc dependent cholangiocarcinogenesis.

D. Calvisi, Xin Chen, A. Cossu, 2019, Journal of hepatology.

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis

D. Calvisi, Xin Chen, S. Ribback, 2020, Cellular and molecular gastroenterology and hepatology.

TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.

D. Calvisi, Xin Chen, Shumei Lin, 2021, Journal of hepatology.

Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models.

Meng Yang, R. Hoffman, Limin Wang, 2018, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Crenigacestat, a selective NOTCH1 inhibitor, reduces intrahepatic cholangiocarcinoma progression by blocking VEGFA/DLL4/MMP13 axis

D. Calvisi, G. Giannelli, Xin Chen, 2020, Cell Death & Differentiation.

SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model.

D. Calvisi, Xin Chen, Meng Xu, 2019, Cancer research.

Oncogene-dependent function of BRG1 in hepatocarcinogenesis

Kairong Cui, K. Zhao, D. Calvisi, 2020, Cell Death & Disease.

Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans

D. Calvisi, Ligong Chen, Xin Chen, 2019, Gut.

Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma

D. Calvisi, Xin Chen, Meng Xu, 2019, Cancers.

Functional role of SGK3 in PI3K/Pten driven liver tumor development

D. Calvisi, Xin Chen, S. Ribback, 2019, BMC Cancer.

β-Catenin sustains and is required for YES-associated protein oncogenic activity in cholangiocarcinoma.

R. Schwabe, D. Calvisi, Sungjin Ko, 2022, Gastroenterology.

Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-β inhibition

D. Calvisi, G. Giannelli, Xin Chen, 2022, Journal of Experimental & Clinical Cancer Research.

TAZ is indispensable for c-MYC-induced hepatocarcinogenesis.

D. Calvisi, Xin Chen, Hong Wu, 2021, Journal of hepatology.

Oncogene-dependent function of BRG1 in hepatocarcinogenesis

Kairong Cui, K. Zhao, D. Calvisi, 2020, Cell Death and Disease.

Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma

D. Calvisi, Xin Chen, Meng Xu, 2019, Cancers.

YAP Accelerates NOTCH Driven Cholangiocarcinogenesis via mTORC1 in Mice.

D. Calvisi, Xin Chen, Hongwei Xu, 2021, The American journal of pathology.